Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

dbMCS: A Database for Exploring the Mutation Markers of Anti-Cancer Drug Sensitivity.

IEEE journal of biomedical and health informatics - 1 Nov 2021

Shen Yueyue, Zhang Youhua, Xue Wei, Yue Zhenyu

Abstract excerpt

The identification of mutation markers and the selection of appropriate treatment for patients with specific genome mutations are important steps in the development of targeted therapies and the realization of precision medicine for human cancers. To investigate the baseline characteristics of drug sensitivity markers and develop computational methods of mutation effect prediction, we presented a manually curated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Databases, Factual
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 34314366
DOI: 10.1109/JBHI.2021.3100424

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

dbMCS: A Database for Exploring the Mutation Markers of Anti-Cancer Drug Sensitivity.PMID 34314366Read ↗

mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers.Semantic proximity Read ↗

Methods and resources to access mutation-dependent effects on cancer drug treatment.Semantic proximity Read ↗

Integrative Statistical Inferences for Drug Sensitivity Biomarkers in CancerSemantic proximity Read ↗

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.Semantic proximity Read ↗

Single nucleotide and copy number variants of cancer driver genes inform drug response in multiple cancers.Semantic proximity Read ↗

The signature of pharmaceutical sensitivity based on ctDNA mutation in eleven cancers.Semantic proximity Read ↗

Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell linesSemantic proximity Read ↗

CancerDR: cancer drug resistance database.Semantic proximity Read ↗

An integrative resource for investigating genetic model of drug response in cancerSemantic proximity Read ↗

Somatic mutation patterns and compound response in cancers.Semantic proximity Read ↗

Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.Semantic proximity Read ↗

Drug Sensitivity Prediction From Cell Line-Based Pharmacogenomics Data: Guidelines for Developing Machine Learning ModelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.